An experience of sequental use of three biologics and recombinant growth hormone in a patient with juvenile idiopathic arthritis associated with unsuccessful outcome of hip damage

類似資料

• PReS-FINAL-2076: Single centre experience of biologics in clinical practice of systemic juvenile idiopatic arthritis
  著者:: Kaleda, MI, 等
  出版事項: (2013)
• Growth retardation in patients with juvenile idiopathic arthritis and growth hormone therapy
  著者:: Nikishina, I, 等
  出版事項: (2008)
• INFLIXIMAB IN TREATMENT OF REFRACTORY JUVENILE ARTHRITIS
  著者:: I.P. Nikishina, 等
  出版事項: (2010-01-01)
• Tocilizumab therapy in systemic juvenile idiopathic arthritis – lessons of real clinical practice
  著者:: Kaleda, Maria I, 等
  出版事項: (2014)
• PReS-FINAL-2061: Abatacept in therapy of juvenile idiopathic arthritis in real clinical practice
  著者:: Arsenyeva, SV, 等
  出版事項: (2013)